Jasper Therapeutics
JSPR
53 hedge funds and large institutions have $82.7M invested in Jasper Therapeutics in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 7 closing their positions.
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
4% more funds holding
Funds holding: 51 → 53 (+2)
2% more capital invested
Capital invested by funds: $81M → $82.7M (+$1.74M)
15% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 13
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$3.56M |
| 2 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$3.18M |
| 3 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
+$1.69M |
| 4 |
OCAM
Owl Creek Asset Management
New York
|
+$1.52M |
| 5 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$1.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
|
-$4.75M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$4.57M |
| 3 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
-$2.1M |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$938K |
| 5 |
Goldman Sachs
New York
|
-$651K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
UBS Group
Zurich,
Switzerland
| $13K | -$35.8K | -352 | -73% |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| $1K | -$3.56K | -35 | -88% |
|
53
Walleye Capital
New York
| $748 | -$107K | -1,054 | -12% |
|
|
PSAMP
54
P. Schoenfeld Asset Management (PSAM)
New York
| – | -$4.75M | -47,500 | Closed |
|
|
UOC
55
UBS O'Connor
Chicago,
Illinois
| – | -$4.57M | -45,625 | Closed |
|
|
AIMCA
56
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
| – | -$2.1M | -21,000 | Closed |
|
|
57
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
| – | -$938K | -9,375 | Closed |
|
|
CL
58
CSS LLC
Chicago,
Illinois
| – | -$549K | -5,483 | Closed |
|
59
Geode Capital Management
Boston,
Massachusetts
| – | -$258K | -2,563 | Closed |
|
|
CAC
60
Cowen and Company
New York
| – | -$250K | -2,500 | Closed |
|
JSPR Hedge Fund Activity: Q1 2021 in Review
53 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Jasper Therapeutics (JSPR) for Q1 2021, worth a combined $82.7M — up 2.1% from $81M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new JSPR positions and 7 closed out — a net gain of 3 holders — while 11 added to existing stakes and 13 trimmed.
The largest buyer was Shaolin Capital Management, adding an estimated $3.56M. The largest seller was P. Schoenfeld Asset Management (PSAM), exiting entirely with an estimated $4.75M sold.
- 53 institutional investors held Jasper Therapeutics (JSPR) as of Q1 2021, up from 51 in Q4 2020.
- Funds reported $82.7M of Jasper Therapeutics stock for Q1 2021, up 2.1% quarter-over-quarter.
- 10 funds opened new Jasper Therapeutics positions in Q1 2021 and 7 closed out, a net change of +3 holders.
- The largest Jasper Therapeutics buyer in Q1 2021 was Shaolin Capital Management, an estimated $3.56M added.
- The largest Jasper Therapeutics seller in Q1 2021 was P. Schoenfeld Asset Management (PSAM), an estimated $4.75M sold.
Based on aggregated 13F filings for Q1 2021.